GlassScriptPhysician profile
Neil Nagda
NPI 1508327842
$7,491.99
in general payments reported to CMS, 2019-2025
16 companies · $3,009 in 2025
The $3,009 reported for 2025 was more than what 88% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $169 · 2023: $2,295 · 2024: $2,018 · 2025: $3,009.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,949 · Travel and Lodging: $1,489 · Education: $885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,949.06 |
| Travel and Lodging | $1,488.51 |
| Education | $885.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,745.00 | 2023-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Nevro Corp. | $1,294.98 | 2023-2024 | Senza |
| Medtronic, INC. | $465.21 | 2024-2025 | Intellis Adaptivestim, Synchromedii |
| Spr Therapeutics, INC | $289.57 | 2024-2025 | Sprint Pns System |
| Saluda Medical Americas, INC. | $268.43 | 2025 | Evoke |
| Nalu Medical, INC. | $235.74 | 2025 | Nalu Neurostimulation System |
| Protega Pharmaceutials INC | $199.75 | 2025 | Roxybond |
| Edwards Lifesciences Corporation | $169.36 | 2022 | |
| Globus Medical, INC. | $160.24 | 2025 | Vyrsa V1, Senza |
| Abbott Laboratories | $149.09 | 2025 | Proclaim |
| Foundation Fusion Solutions, LLC | $141.01 | 2024-2025 | |
| Mml US, INC. | $123.50 | 2025 | Reactiv8 |
| Abbvie INC. | $83.55 | 2025 | |
| Spinal Simplicity, LLC | $75.08 | 2024-2025 | Ha Minuteman G3-R |
| Si-Bone, INC. | $51.92 | 2024-2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $39.56 | 2025 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Nagda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.